We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLWS icon
3051
1-800-Flowers.com
FLWS
$265M
$139K ﹤0.01%
14,300
FSM icon
3052
Fortuna Silver Mines
FSM
$2.91B
$139K ﹤0.01%
28,368
-8,125
-22% -$39K
AUD
3053
DELISTED
Audacy, Inc.
AUD
$139K ﹤0.01%
+13,419
New +$151K
NVIV
3054
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$139K ﹤0.01%
3
-3
-50% -$164K
NDP
3055
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
$136K ﹤0.01%
1,279
-95
-7% -$11.4K
HTZ
3056
DELISTED
Hertz Global Holdings, Inc.
HTZ
$136K ﹤0.01%
+13,590
New +$146K
GNRT
3057
DELISTED
Gener8 Maritime, Inc.
GNRT
$136K ﹤0.01%
23,841
+3,469
+17% +$18.6K
MIXT
3058
DELISTED
MIX TELEMATICS LIMITED
MIXT
$132K ﹤0.01%
16,769
-250
-1% -$1.66K
IID
3059
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$132K ﹤0.01%
17,848
ALDR
3060
DELISTED
Alder Biopharmaceuticals
ALDR
$130K ﹤0.01%
11,342
-6,847
-38% -$127K
CRUS icon
3061
CALL
Cirrus Logic
CRUS
$6.53B
$129K ﹤0.01%
46,600
+30,100
+182% +$1.95M
EVP
3062
DELISTED
Eaton Vance Pennsylvania Municipal Income Trust
EVP
$129K ﹤0.01%
10,573
-3,840
-27% -$46.9K
BKT icon
3063
BlackRock Income Trust
BKT
$339M
$128K ﹤0.01%
6,716
+2,215
+49% +$41.6K
HIG icon
3064
CALL
Hartford Financial Services
HIG
$39.4B
$127K ﹤0.01%
+73,700
New +$3.65M
TT icon
3065
CALL
Trane Technologies
TT
$106B
$126K ﹤0.01%
16,600
-100
-0.6% -$8.77K
CHS
3066
DELISTED
Chicos FAS, Inc.
CHS
$126K ﹤0.01%
+13,356
New +$154K
CVRR
3067
DELISTED
CVR Refining, LP
CVRR
$124K ﹤0.01%
13,098
MNKD icon
3068
MannKind Corp
MNKD
$1.27B
$123K ﹤0.01%
87,182
+30,680
+54% +$39.5K
LUNA
3069
DELISTED
Luna Innovations Incorporated
LUNA
$123K ﹤0.01%
81,459
GFI icon
3070
Gold Fields
GFI
$33.4B
$122K ﹤0.01%
+34,955
New +$126K
UAN icon
3071
CVR Partners
UAN
$1.34B
$121K ﹤0.01%
3,476
+896
+35% +$39K
DSE
3072
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$120K ﹤0.01%
1,692
+42
+3% +$3.09K
SGYP
3073
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$120K ﹤0.01%
26,943
-39,299
-59% -$162K
WIN
3074
DELISTED
Windstream Holdings Inc
WIN
$119K ﹤0.01%
6,116
+3,362
+122% +$81.3K
ATW
3075
DELISTED
Atwood Oceanics
ATW
$119K ﹤0.01%
14,585
+2,385
+20% +$20.5K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.